BEKHealth has announced a new commercially available service to help pharmaceutical companies design clinical trials compatible with the latest AI solutions used by research organizations at trial sites.
A BEKScore is generated by evaluating the design and criteria of a trial protocol and determining how likely an AI solution will be to find trial candidates within an EMR database. The higher the BEKScore, the greater the chance an AI-powered search will produce enough eligible participants to meet the requirements of the protocol.
